Distillate US Fundamental Stability & Value ETF
DSTL - ETF AI Analysis
Top Page
Distillate US Fundamental Stability & Value ETF (DSTL)
DSTL, the Distillate US Fundamental Stability & Value ETF, earns a solid overall rating thanks to strong, diversified holdings like Merck, Salesforce, Accenture, and UnitedHealth, which combine robust financial performance, attractive or fair valuations, and long-term growth initiatives in areas such as AI and healthcare. The rating is held back somewhat by positions like Booking Holdings and Altria, where high leverage, technical weaknesses, and sector-specific challenges add risk, making the main concern the fund’s exposure to companies with elevated debt and valuation pressures even within an otherwise fundamentally stable portfolio.
DSTL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.20B
- Region
- North America
- Expense Ratio
- 0.39%
- Beta
- 0.64
- Issuer
- Distillate
- Inception Date
- Oct 24, 2018
- Dividend Yield
- 1.03%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DSTL Summary
DSTL is the Distillate US Fundamental Stability & Value ETF, which invests in large U.S. companies that appear financially strong and reasonably priced, rather than tracking a specific index. It focuses on firms with steady business results and solid cash flows across many sectors, including technology, health care, and industrials. Well-known holdings include Accenture and UnitedHealth. Someone might invest in DSTL to get diversified exposure to high-quality U.S. stocks with a value tilt, aiming for growth with some focus on stability. A key risk is that the fund still holds stocks, so its value can go up and down with the overall market.
How much will it cost me?
DSTL has an expense ratio of 0.39%, which means you’ll pay about $3.90 per year for every $1,000 invested. This is higher than the cost of many broad, passively managed index ETFs because DSTL is actively managed and uses a specialized strategy to select stable, value-oriented large U.S. companies.
What would affect this ETF?
DSTL could benefit if the U.S. economy stays resilient, interest rates eventually ease, and large, financially strong companies in technology and health care continue to grow, supporting its focus on stable, value-oriented U.S. stocks like UnitedHealth, Accenture, and Salesforce. On the other hand, prolonged high interest rates, weaker U.S. growth, regulatory changes in health care, energy, or tech, or a shift in market preference away from value stocks could weigh on the ETF’s future performance.
DSTL Top 10 Holdings
DSTL leans heavily into U.S. large caps with a tilt toward steady growers rather than flashy momentum plays. Health care names like UnitedHealth and Merck are quietly pulling their weight, offering rising, defensive performance that helps smooth out bumps elsewhere. AbbVie and Altria add a value flavor, staying relatively steady despite sector headwinds. On the flip side, tech and digital leaders such as Adobe, Salesforce, and Booking have been lagging, acting like a headwind just as Marathon Petroleum’s strong run provides a boost. Overall, it’s a U.S.-centric, quality-first mix with a few growth engines currently losing steam.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Accenture | 2.11% | $46.38M | $146.40B | 1.02% | 79Outperform | |
| AbbVie | 2.00% | $44.01M | $520.65B | 26.76% | 66Neutral | |
| UnitedHealth | 2.00% | $44.01M | $369.18B | 28.01% | 72Outperform | |
| Merck & Company | 1.86% | $40.95M | $356.13B | 55.47% | 80Outperform | |
| Comcast | 1.84% | $40.42M | $90.91B | -6.94% | 74Outperform | |
| Salesforce | 1.76% | $38.63M | $176.81B | -11.83% | 80Outperform | |
| Marathon Petroleum | 1.65% | $36.27M | $109.51B | 101.12% | 66Neutral | |
| Lowe's | 1.52% | $33.47M | $126.20B | -1.28% | 69Neutral | |
| Altria Group | 1.52% | $33.44M | $131.25B | 35.59% | 64Neutral | |
| Regeneron | 1.51% | $33.20M | $98.51B | 37.33% | 78Outperform |
DSTL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DSTL, the sentiment is Positive. The current price of 70.75 is above the 20-day moving average (MA) of 69.95, above the 50-day MA of 67.53, and above the 200-day MA of 62.83, indicating a bullish trend. The MACD of 1.01 indicates Negative momentum. The RSI at 58.62 is Neutral, neither overbought nor oversold. The STOCH value of 51.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DSTL.
DSTL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $70.75 | $77.00(8.83% Upside) | $2.20B | 0.39% | 72Outperform | |
| $41.56 | $48.87(17.59% Upside) | $7.49B | 0.21% | 73Outperform | |
| $83.67 | $97.08(16.02% Upside) | $7.66B | 0.44% | 71Outperform | |
| $43.31 | $50.17(15.83% Upside) | $3.79B | 0.18% | 72Outperform | |
| $49.01 | $58.93(20.23% Upside) | $1.63B | 0.15% | 72Outperform | |
| $57.46 | $67.14(16.85% Upside) | $1.40B | 0.59% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DSTL | Distillate US Fundamental Stability & Value ETF | 70.75 | 14.78 | 26.40% | |
| DFLV | Dimensional US Large Cap Value ETF | 41.56 | 9.44 | 29.37% | |
| JAVA | JPMorgan Active Value ETF | 83.67 | 15.92 | 23.50% | |
| FELV | Fidelity Enhanced Large Cap Value ETF | 43.31 | 10.58 | 32.33% | |
| SEIV | SEI Enhanced U.S. Large Cap Value Factor ETF | 49.01 | 10.48 | 27.20% | |
| DUSA | Davis Select U.S. Equity ETF | 57.46 | 10.70 | 22.90% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
